The global Alpers Disease Treatment Market Share is a critical, albeit niche, segment within the broader rare and neurological disease therapeutic areas. Alpers disease, also known as Alpers-Huttenlocher Syndrome (AHS), is a rare, progressive, and fatal neurodegenerative disorder predominantly affecting the brain and liver, caused by mutations in the $POLG$ gene. This market...

Executive Summary: Antihistamine Drugs Market Size and Share by Application & Industry The global antihistamine drugs market size was valued at USD 305.85 million in 2024 and is expected to reach USD 620.71 million by 2032, at a CAGR of 9.25% during the forecast period   For the growth of business, Antihistamine Drugs Market analysis report...

  The  Lurbinectedin Market has emerged as a notable niche within the oncology therapeutics landscape, driven by advancements in targeted cancer treatments and rising incidence of small cell lung cancer (SCLC) and select solid tumors. The lurbinectedin market is expected to witness market growth at a rate of 45.30% in the forecast period of 2022 to...